First described by Alois Alzheimer in 1906, the extracellular deposition of amyloid-beta peptides (Aβ) and the accumulation of hyperphosphorylated tau proteins have been recognized as the hallmarks of AD [2,3]. The gene discussed is MAPT; the disease is Alzheimer disease.